围手术期地塞米松对行全髋或全膝关节置换术患者的影响:对糖尿病患者是否安全?
该回顾性研究纳入2011至2015年行初次全关节置换术的2317例患者,分为地塞米松组(1426例)与未用地塞米松组(891例),并进一步分为糖尿病与非糖尿病亚组。结果显示地塞米松未影响假体周围感染率(P=.166),糖尿病患者总体感染率更高(P<.001),但接受地塞米松的糖尿病患者感染率与非糖尿病患者无显著差异(P=.646);地塞米松也未增加术后血糖升高(P=.537)。
要点
- 地塞米松未增加全关节置换术后假体周围感染率(P=.166)。
- 糖尿病患者总体感染率更高(P<.001),但地塞米松未使糖尿病患者感染率显著高于非糖尿病患者(P=.646)。
- 地塞米松未增加术后血糖升高(P=.537),糖尿病(P<.001)和糖化血红蛋白升高(P<.001)与血糖升高相关。
核心结论
- 糖尿病患者总体感染率更高,但静脉给予地塞米松未影响感染率,也未影响术后血清葡萄糖升高。
- 在该研究人群中,围手术期静脉地塞米松未增加假体周围感染率,用于全关节置换术患者是安全的。
研究设计与样本
- 回顾性病历审查,纳入2011至2015年所有接受初次全关节置换术的患者(n=2317)。
- 患者分为地塞米松组(n=1426)和未用地塞米松组(n=891),两组再分为糖尿病和非糖尿病亚组。
- 主要结局为假体周围感染,次要指标包括血糖水平和术前糖化血红蛋白值;统计采用逻辑回归和回归模型。
主要发现
- 2317个关节中1.12%发生假体周围感染,地塞米松未影响其发生率(P=.166)。
- 糖尿病患者感染率更高(P<.001);但接受地塞米松的糖尿病患者感染率未显著高于非糖尿病患者(P=.646)。
- 术后血糖水平升高,地塞米松未增加这一变化(P=.537)。
- 糖尿病(P<.001)和糖化血红蛋白升高(P<.001)与血清葡萄糖水平升高相关,但不受地塞米松影响(P=.595)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peri-operative dexamethasone has been shown to effectively reduce post-operative nausea and vomiting and aide in analgesia after total joint arthroplasty (TJA); however, systemic glucocorticoid therapy has many adverse effects. The purpose of this study is to determine the effects of dexamethasone on prosthetic joint infection (PJI) and blood glucose levels in patients undergoing TJA. METHODS: A retrospective chart review of all patients receiving primary TJA from 2011 to 2015 (n = 2317) was conducted. Patients were divided into 2 cohorts: dexamethasone (n = 1426) and no dexamethasone (n = 891); these groups were subdivided into diabetic and non-diabetic patients. The primary outcome was PJI; secondary measures included glucose levels and pre-operative hemoglobin A1c (A1c) values. Statistics were carried out using logistic and regression models. RESULTS: Of the 2317 joints, 1.12% developed PJI; this was not affected by dexamethasone (P = .166). Diabetics were found to have higher rate of infection (P < .001); however, diabetics who received dexamethasone were not found to have a significantly higher infection rate that non-diabetics (P = .646). Blood glucose levels were found to increase post-operatively, and dexamethasone did not increase this change (P = .537). Diabetes (P < .001) and increasing hemoglobin A1c (P < .001) were also associated with increased serum glucose levels; however, this was not influenced by dexamethasone (P = .595). CONCLUSION: Although diabetic patients were found to have a higher infection rate overall, this was not affected by administration of intravenous dexamethasone, nor was the post-operative elevation in serum glucose levels. In this study population, peri-operative intravenous dexamethasone did not increase the rate of PJI and was safe to administer in patients undergoing TJA.
引用
- Godshaw BM, Mehl AE, Shaffer JG, et al. The Effects of Peri-Operative Dexamethasone on Patients Undergoing Total Hip or Knee Arthroplasty: Is It Safe for Diabetics? J Arthroplasty. 2018. PMID: 30612830. doi:10.1016/j.arth.2018.12.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。